Scandinavian Medical Solutions AS (OCSE:SMSMED) Debt-to-EBITDA : 2.39 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Scandinavian Medical Solutions AS Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Scandinavian Medical Solutions AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was kr10.9 Mil. Scandinavian Medical Solutions AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was kr17.7 Mil. Scandinavian Medical Solutions AS's annualized EBITDA for the quarter that ended in Sep. 2023 was kr12.0 Mil. Scandinavian Medical Solutions AS's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 2.39.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Scandinavian Medical Solutions AS's Debt-to-EBITDA or its related term are showing as below:

OCSE:SMSMED' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01 Med: 0.06 Max: 1.35
Current: 1.35

During the past 5 years, the highest Debt-to-EBITDA Ratio of Scandinavian Medical Solutions AS was 1.35. The lowest was 0.01. And the median was 0.06.

OCSE:SMSMED's Debt-to-EBITDA is ranked worse than
52.53% of 434 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs OCSE:SMSMED: 1.35

Scandinavian Medical Solutions AS Debt-to-EBITDA Historical Data

The historical data trend for Scandinavian Medical Solutions AS's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandinavian Medical Solutions AS Debt-to-EBITDA Chart

Scandinavian Medical Solutions AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-EBITDA

0.03

0.09

0.01

1.35

Scandinavian Medical Solutions AS Semi-Annual Data
	Sep19	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-EBITDA	Get a 7-Day Free Trial			-	0.07	0.01	0.35	2.39

Competitive Comparison of Scandinavian Medical Solutions AS's Debt-to-EBITDA

For the Medical Devices subindustry, Scandinavian Medical Solutions AS's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scandinavian Medical Solutions AS's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Scandinavian Medical Solutions AS's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Scandinavian Medical Solutions AS's Debt-to-EBITDA falls into.

Scandinavian Medical Solutions AS Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Scandinavian Medical Solutions AS's Debt-to-EBITDA for the fiscal year that ended in Sep. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(10.914	+	17.69)	/	21.225
	=	1.35

Scandinavian Medical Solutions AS's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(10.914	+	17.69)	/	11.95
	=	2.39

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Sep. 2023) EBITDA data.

Scandinavian Medical Solutions AS (OCSE:SMSMED) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Scandinavian Medical Solutions AS Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Scandinavian Medical Solutions AS's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Scandinavian Medical Solutions AS (OCSE:SMSMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Scandinavian Medical Solutions AS (OCSE:SMSMED) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

K41:Germany

Address

Gasvaerksvej 46. 1.Sal, Aalborg, DNK, DK-9000

Website

https://www.scandinavian-medical.com

Scandinavian Medical Solutions AS is engaged in offering pre-owned medical imaging equipment and innovative healthcare solutions. The product portfolio of Cath Lab, X-Ray, MRI, Mammography, Ultrasound, and Mobile X-Ray among others.

Scandinavian Medical Solutions AS (OCSE:SMSMED) Headlines

No Headlines